Loading...

Viridian Therapeutics, Inc.

0K1R.L•LSE
Healthcare
Biotechnology
£17.43
£0.05(0.29%)

Viridian Therapeutics, Inc. (0K1R.L) Stock Chart & Performance Analysis

Explore Viridian Therapeutics, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
5.48%
5-Day Change
-6.16%
1-Month Change
-29.45%
3-Month Change
-39.59%
6-Month Change
-49.47%
Year-to-Date (YTD) Change
-44.12%
1-Year Change
-30.66%
3-Year Change
-41.34%
5-Year Change
19.89%
All-Time (Max) Change
-91.48%

Analyzing Viridian Therapeutics, Inc. (0K1R.L) Trends Across Multiple Time Frames

Viridian Therapeutics, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Viridian Therapeutics, Inc. stock shows 5.48% 1-day change, indicating immediate volatility, while its 5-day change of -6.16% suggests a broader trend. Over a 1-month period, a -29.45% drop could signal a pullback, whereas a 3-month decline of -39.59% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -49.47% and a YTD drop of -44.12% might concern investors, but a 1-year loss of -30.66% and a 3-year drop of -41.34% could indicate resilience. The 5-year surge of 19.89% highlights strong historical growth, while the all-time return of -91.48% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;